Patents by Inventor Cheng-Shun Lai

Cheng-Shun Lai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glycyrrhizinates of morphinan derivatives
    Patent number: 8557784
    Abstract: The present invention provides a pharmaceutically acceptable compound, a pharmaceutical composition comprising the above-mentioned pharmaceutically acceptable compound. The pharmaceutically acceptable compound provided by the present invention is a salt of a basic group-containing morphinan derivative and a carboxyl group-containing glycyrrhizinic acid and has the ability to be used to manufacture medicaments for treating and/or preventing cough, ameliorating pains, treating respiratory system diseases, treating cardiovascular diseases and treating liver diseases.
    Type: Grant
    Filed: July 7, 2011
    Date of Patent: October 15, 2013
    Assignee: Standard Chem. & Pharm. Co., Ltd.
    Inventors: Chin-Tsai Fan, Cheng-Shun Lai, Wen-Yen Yeh, Yu-Ying Liu
  • GLYCYRRHIZINATES OF MORPHINAN DERIVATIVES
    Publication number: 20130012464
    Abstract: The present invention provides a pharmaceutically acceptable compound, a pharmaceutical composition comprising the above-mentioned pharmaceutically acceptable compound. The pharmaceutically acceptable compound provided by the present invention is a salt of a basic group-containing morphinan derivative and a carboxyl group-containing glycyrrhizinic acid and has the ability to be used to manufacture medicaments for treating and/or preventing cough, ameliorating pains, treating respiratory system diseases, treating cardiovascular diseases and treating liver diseases.
    Type: Application
    Filed: July 7, 2011
    Publication date: January 10, 2013
    Inventors: Chin-Tsai FAN, Cheng-Shun Lai, Wen-Yen Yeh, Yu-Ying Liu
  • Pharmaceutically acceptable salts of aporphine derivatives and carboxyl group-containing agents and methods for preparing the same
    Patent number: 8202995
    Abstract: The present invention discloses novel pharmaceutically acceptable salts of aporphine compounds and carboxyl-group containing agents. Also, the present invention discloses methods for preparing the pharmaceutically acceptable salts. These pharmaceutically acceptable salts are suitable for use in treating and/or preventing hyperglycemic disease and/or several oxidative stress related diseases.
    Type: Grant
    Filed: June 19, 2009
    Date of Patent: June 19, 2012
    Assignee: Standard Chem. & Pharm. Co., Ltd.
    Inventors: Chin-Tsai Fan, Cheng-Shun Lai, Mei-Jung Lin
  • Aporphine derivatives and pharmaceutical use thereof
    Patent number: 8093260
    Abstract: The present invention discloses novel aporphine derivatives. Also, the present invention discloses that these novel aporphine derivatives can be used for treating oxidative stress induced diseases such as cardiovascular disease, diabetes, aging, Alzheimer's disease, kidney disease, cancer or brain ischemic disease etc.
    Type: Grant
    Filed: June 19, 2009
    Date of Patent: January 10, 2012
    Assignee: Standard Chem. & Pharm. Co., Ltd.
    Inventors: Chin-Tsai Fan, Cheng-Shun Lai, Mei-Jung Lin
  • Pharmaceutically acceprable salts of aporphine compounds of carboxyl group-containing agents and methods for preparing the same
    Publication number: 20090318488
    Abstract: The present invention discloses novel pharmaceutically acceptable salts of aporphine compounds and carboxyl-group containing agents. Also, the present invention discloses methods for preparing the pharmaceutically acceptable salts. These pharmaceutically acceptable salts are suitable for use in treating and/or preventing hyperglycemic disease and/or several oxidative stress related diseases.
    Type: Application
    Filed: June 19, 2009
    Publication date: December 24, 2009
    Applicant: Standard Chem. & Pharm. Co., Ltd.
    Inventors: Chin-Tsai Fan, Cheng-Shun Lai, Mei-Jung Lin
  • Aporphine compounds and pharmaceutical use thereof
    Publication number: 20090318489
    Abstract: The present invention discloses novel aporphine derivatives. Also, the present invention discloses that these novel aporphine derivatives can be used for treating oxidative stress induced diseases such as cardiovascular disease, diabetes, aging, Alzheimer's disease, kidney disease, cancer or brain ischemic disease etc.
    Type: Application
    Filed: June 19, 2009
    Publication date: December 24, 2009
    Applicant: Standard Chem. & Pharm. Co., Ltd.
    Inventors: Chin-Tsai Fan, Cheng-Shun Lai, Mei-Jung Lin